A Forward Look, The Year Ahead - Featured Research on Momenta Pharmaceuticals, Inc. and Cubist Pharmaceuticals Inc
February 15 2012 - 9:00AM
Marketwired
Today, www.BollingerReport.com introduced featured coverage of
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) and Cubist
Pharmaceuticals Inc (NASDAQ: CBST). Full research reports are
available to readers at:
www.BollingerReport.com/index.php?sm1=MNTA&sm2=CBST.
Economic fundamentals leading into 2012 have set a generally
positive pace with GDP growth likely to pick up through the coming
year. However, there are several important caveats to note as the
world economy continues to face headwinds and risks weigh to the
downside. Positive outlooks are conditional on fiscal policy in
payroll taxes and unemployment insurance benefits and upon the
easing of the European debt situation. A repeat of volatility
experience in 2011 is likely in 2012, as perceptions about the
strength of the U.S. economy and the euro zone will vary over time
as events unfold.
Despite the current situation, our team continues to identify
high momentum situations with growth potential - there remains
strong opportunity within careful discretion.
Bollinger Report screened and selected Momenta Pharmaceuticals,
Inc. for its current position within the healthcare industry.
Momenta Pharmaceuticals, Inc. (Momenta) is a biotechnology company
specializing in the characterization and process engineering of
complex molecules. These complex molecules include proteins,
polypeptides, and cell surface polysaccharides, such as
heparan-sulfate proteoglycans (HSPGs). A copy of this report
featuring Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is available
at: www.BollingerReport.com/index.php?sm1=MNTA.
Bollinger Report is featuring Cubist Pharmaceuticals Inc for its
changing role within the healthcare industry. Cubist
Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company
focused on the research, development and commercialization of
pharmaceutical products that address unmet medical needs in the
acute care environment. The Company's products are used primarily
in hospitals, but also may be used in acute care settings,
including home infusion and hospital outpatient clinics. To
download researches and analysis on Cubist Pharmaceuticals Inc
(NASDAQ: CBST) we welcome investors to visit:
www.BollingerReport.com/index.php?sm2=CBST.
About Bollinger Report Bollinger Report has come to be known
among its peers as a trusted source of information for both
investors and technical traders. Our online content is continually
updated, bringing fresh new researches and analyses to the
investment community.
Contact: Martin Schwartz Email Contact
www.BollingerReport.com